A windfall year at NIH

This has been a boom year at the National Institutes of Health. With a $10 billion infusion thanks to the American Recovery and Reinvestment Act of 2009, the agency found itself in the unfamiliar position of being flush with cash. As Congress decides how it will fund the NIH and the nation's other federal science agencies in 2010 and 2011, we take a look back at scientists and fields of research that scored big this year. The following are 2009's ten most funded Research, Condition, and Disease

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
This has been a boom year at the National Institutes of Health. With a $10 billion infusion thanks to the American Recovery and Reinvestment Act of 2009, the agency found itself in the unfamiliar position of being flush with cash. As Congress decides how it will fund the NIH and the nation's other federal science agencies in 2010 and 2011, we take a look back at scientists and fields of research that scored big this year. The following are 2009's ten most funded Research, Condition, and Disease Categories, according to the NIH:
Image: US Dept. of the Treasury
Clinical Research - $9,931,000
Genetics - $7,066,000
Cancer - $5,748,000
Biotechnology - $5,390,000
Neurosciences - $5,372,000
Prevention - $4,752,000
Brain Disorders - $3,835,000
Infectious Diseases - $3,678,000
Clinical Trials - $3,663,000
Women's Health - $3,627,000 NIH's stimulus boost provided a lot of funding and new grants to investigators in 2009. Researchers applied in droves for linkurl:NIH Challenge Grants in Health and Science Research,;http://grants.nih.gov/grants/funding/challenge_award/ and dozens of scientists pulled in linkurl:Director's Pioneer Awards;http://nihroadmap.nih.gov/pioneer/ of more than $2 million. Here are the five fattest R01 grants that flew out the NIH's doors this year. Principal Investigator: Pamela Douglas
Institution: Duke University
R01 Grant: $5,566,450
Project Description: The PROMISE (PROspective Multicenter Imaging Study for Evaluation of Chest Pain) Trial. A study to assess the efficacy of coronary computed tomographic angiography in initially testing 10,000 patients complaining of chest pain.
Administered by: The National Heart Lung and Blood Institute Principal Investigator: Jonine Bernstein
Institution: Sloan-Kettering Institute for Cancer Research
R01 Grant: $3,562,856
Project Description: Genome-wide Association Study of Radiation Exposure and Bilateral Breast Cancer. A study to delineate the joint roles of genetic predisposition and radiation exposure in the etiology of second primary breast cancer using a genome-wide association (GWA) approach in more than 1,500 women with bilateral breast cancer.
Administered by: The National Cancer Institute Principal Investigator: Thomas Vaughan
Institution: Fred Hutchinson Cancer Research Center
R01 Grant: $3,448,940
Project Description: Barrett's and Esophageal Adenocarcinoma Genetic Susceptibility Study (BEAGESS). A genome-wide association study to evaluate the influence of genetic susceptibility on risk of esophageal adenocarcinoma -- a cancer who's prevalence in the US has increased by 500 percent in the last 30 years -- and its precursor, Barrett's esophagus.
Administered by: The National Cancer Institute Principal Investigator: Russell Ware
Institution: St. Jude Children's Research Hospital
R01 Grant: $3,387,494
Project Description: Transcranial Doppler with Transfusions Changing to Hydroxyurea. A trial is to compare two years of hydroxyurea therapy with standard transfusion therapy to prevent stroke in children with sickle cell anemia.
Administered by: The National Heart Lung and Blood Institute Principal Investigator: Michele Sale
Institution: University of Virginia Charlottesville
R01 Grant: $3,008,855
Project Description: Genetic Contributions to Diabetes and Dyslipidemia in African Americans. A genome-wide association study to assess the genetic risk factors for type 2 diabetes among a population of more than 1,000 African Americans from the Sea Islands of South Carolina and Georgia.
Administered by: The National Institute of Diabetes and Digestive and Kidney Diseases and the Office of the Director A New Year's bonus: Our friends over at the Medical Writing, Editing, and Grantsmanship blog recently posted a time line and guide to submitting new NIH proposals in 2010. Check it out linkurl:here.;http://writedit.wordpress.com/2009/12/09/best-timing-for-nih-applications/
**__Related stories:__***linkurl:2010 budget on Obama's desk;http:http://www.the-scientist.com/blog/display/56217/
[14th December 2009]*linkurl:2010 NIH budget bump;http://www.the-scientist.com/blog/display/56211/
[10th December 2009]*linkurl:NIH 2010 budget tweaked;http:http://www.the-scientist.com/blog/display/55870/
[30th July 2009]
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies